Evaluating heart health in patients with high blood pressure
Official title: Subendocardial Viability Ratio in Hypertension
Run by Istituto Auxologico Italiano · NCT06309511 · Data updated 2026-11-12
This study tests a new way to check heart health in people with high blood pressure to see if it can help predict heart-related problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 5 sites (Mascalucia, Catania and 4 other locations) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 3, 2025 |
| Trial ID | NCT06309511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with hypertension.
✕Probably not a fit
Patients with atrial fibrillation will not benefit from this study due to exclusion criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to assess the Subendocardial Viability Ratio (SEVR) in patients with hypertension using non-invasive arterial tonometry. The study will measure the SEVR by analyzing the central pressure wave morphology and correlating it with various anthropometric and pathology variables. By understanding the SEVR, the study seeks to identify factors that may predict cardiovascular morbidity and mortality in individuals with high blood pressure. Participants will be recruited from specialized Arterial Hypertension Centers.
Why it matters
Potential benefit: If successful, this study could help predict cardiovascular risks in hypertensive patients, leading to better management and treatment strategies.
How similar studies have gone: Other studies have explored similar methodologies in assessing cardiovascular health in hypertensive patients, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hypertension Exclusion Criteria: * Atrial fibrillation
Where it's running
-
Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi"
Mascalucia, Catania, Italy Recruiting -
Unità Operativa Semplice Dipartimentale Ipertensione Arteriosa "Anna Maria Pirrelli", Università degli Studi di Bari "Aldo Moro". Policlinico Consorziale di Bari
Bari, Italy Recruiting -
Istituto Auxologico Italiano IRCCS
Milan, Italy Recruiting -
Medicina II Cardiovascolare, AUSL-IRCCS di Reggio Emilia
Reggio Emilia, Italy Recruiting -
Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università degli studi di Trieste
Trieste, Italy Recruiting
Study contacts
- Study coordinator: Paolo Salvi, MD
- Email: p.salvi@auxologico.it
- Phone: +390261911
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.